Your browser doesn't support javascript.
loading
B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igß (CD79b) in Normal and Malignant B Cells.
Tkachenko, Anton; Kupcova, Kristyna; Havranek, Ondrej.
  • Tkachenko A; BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic.
  • Kupcova K; BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic.
  • Havranek O; First Department of Internal Medicine-Hematology, General University Hospital and First Faculty of Medicine, Charles University, 128 08 Prague, Czech Republic.
Int J Mol Sci ; 25(1)2023 Dec 19.
Article en En | MEDLINE | ID: mdl-38203179
ABSTRACT
B-cell receptor (BCR) is a B cell hallmark surface complex regulating multiple cellular processes in normal as well as malignant B cells. Igα (CD79a)/Igß (CD79b) are essential components of BCR that are indispensable for its functionality, signal initiation, and signal transduction. CD79a/CD79b-mediated BCR signaling is required for the survival of normal as well as malignant B cells via a wide signaling network. Recent studies identified the great complexity of this signaling network and revealed the emerging role of CD79a/CD79b in signal integration. In this review, we have focused on functional features of CD79a/CD79b, summarized signaling consequences of CD79a/CD79b post-translational modifications, and highlighted specifics of CD79a/CD79b interactions within BCR and related signaling cascades. We have reviewed the complex role of CD79a/CD79b in multiple aspects of normal B cell biology and how is the normal BCR signaling affected by lymphoid neoplasms associated CD79A/CD79B mutations. We have also summarized important unresolved questions and highlighted issues that remain to be explored for better understanding of CD79a/CD79b-mediated signal transduction and the eventual identification of additional therapeutically targetable BCR signaling vulnerabilities.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos B / Transducción de Señal Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos B / Transducción de Señal Idioma: En Año: 2023 Tipo del documento: Article